临床试验

2 型糖尿病合并房颤患者认知与功能结局的性别与年龄差异

来源:In vivo (Athens, Greece) · PMID 42957253 · DOI 10.21873/invivo.14473 · 来源:IMA 知识库《文献层·文献监控卡片》2026-11-01 期 · 摘要级(file_id dlMXdlgtPZzo,实际下载核验) · 摘要级,未获取付费墙全文

时间标签:数据日期 2026-11-01 · 生成时间 2026-11-01 05:30(Asia/Shanghai)| 检索窗口 PubMed edat 2026/10/31–2026/11/01 | 情报发生日期 2026-11-01

证据级别:摘要级。本条依据 PubMed 结构化摘要与元数据撰写,付费墙全文未获取、未逐节核验,本站未做任何数值推算补全。

研究问题

Atrial fibrillation (AF) and type 2 diabetes mellitus (T2DM) are associated with cognitive decline, but possible sex-related differences in cognitive and functional outcomes remain uncertain.

方法

Logistic regression was used to evaluate factors associated with severe cognitive impairment, defined as MMSE <24, in the overall cohort and separately in male and female patients.;Increasing age and higher diastolic blood pressure were associated with higher odds of MMSE <24 in the overall cohort and in sex-stratified analyses.

核心结论

Atrial fibrillation (AF) and type 2 diabetes mellitus (T2DM) are associated with cognitive decline, but possible sex-related differences in cognitive and functional outcomes remain uncertain.;Logistic regression was used to evaluate factors associated with severe cognitive impairment, defined as MMSE <24, in the overall cohort and separately in male and female patients.;Increasing age and higher diastolic blood pressure were associated with higher odds of MMSE <24 in the overall cohort and in sex-stratified analyses.;Higher GDS-15 scores were associated with increased odds of severe cognitive impairment in both sexes, whereas greater functional independence, reflected by higher ADL scores, was associated with lower odds of MMSE <24.

局限

(原文未给出可直接抽取的对应表述)

对本项目的价值

人群纵向证据,可用于假说生成与终点选择:血管老化是全身衰老的先行指标,可与其他时钟做交叉验证。 | 价值分 1.6/5(★★☆☆☆)

全文来源

未取到全文 → 本卡为摘要级解读,未核验全文

原文题录

  • 英文标题:A Comparative Exploratory Study of Cognitive and Functional Outcomes by Sex and Age in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation.
  • 期刊与标识:In vivo (Athens, Greece) · PMID 42957253 · DOI 10.21873/invivo.14473

A 级证据分级:A 级(同行评议人体研究)

本文属人体研究证据,但需注意:观察性或小样本干预的结论不等于已证实临床获益;效应量与长期安全性仍需更大规模、更长随访的试验验证。

关于本文的文献来源:本站依据 IMA 知识库「五刊监控·深度文献卡片」(SOP §4.2 摘要级)撰写,依据期刊公开摘要与 PubMed 元数据;付费墙全文未获取之处已标注「待补全文」,未做任何数值推算补全。